The Tate group develops novel chemical biology technologies to enable drug discovery, collaborates widely to apply these tools to identify actionable targets in disease, and translates our findings toward clinical development. The three key areas of focus in our group include:
Research
Proteomics and post-translational modification (PTM)
Targeted and proximity-induced pharmacology
Contact
Prof. Ed Tate
GSK Chair in Chemical Biology
Department of Chemistry
Molecular Sciences Research Hub, White City Campus,
82 Wood Lane, London, W12 0BZ
e.tate@imperial.ac.uk
Tel: +44 (0)20 759 + ext 43752 or 45821